Solid Tumor Clinical Trials

A listing of Solid Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2008 clinical trials
Phase I of Eribulin and Oral Irinotecan for Relapsed or Refractory Solid Tumors

This Phase I trial will establish the recommended phase II dose of eribulin in combination with fixed doses of oral irinotecan in adolescents and young adults with relapsed or refractory solid

  • 2 views
  • 08 Nov, 2020
  • 1 location
TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors

TLD-1 is a novel liposomal formulation of doxorubicin (PEG surface) that compared favorably to conventional liposomal formulations of doxorubicin including Caelyx® in preclinical in vivo models. Particle features including size, charge distribution, lipid composition and drug release add up to a considerably altered particle behavior compared to Caelyx®, potentially explaining …

  • 23 views
  • 14 Feb, 2022
  • 3 locations
  • 0 views
  • 05 Feb, 2022
  • 1 location
Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

activity profile of the RP2D of OBI-999 in patients with advanced solid tumors.

  • 0 views
  • 19 Apr, 2022
  • 4 locations
Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors

The primary objective of the study is to determine the recommended phase 2 dose (RP2D) of Debio 0123 in combination with carboplatin in participants with advanced solid tumors that recurred or

  • 16 views
  • 24 Mar, 2022
  • 3 locations
Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors

This is an open-label, multicenter, dose-escalation phase I study to assess the safety, tolerability and preliminary efficacy of KN044 in participants with all advanced solid tumors who are not

  • 8 views
  • 24 Feb, 2022
  • 1 location
  • 0 views
  • 24 Feb, 2022
  • 2 locations
Phase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies

metastatic solid tumor malignancies. The purpose of this trial is to determine if combination treatment of drugs, Olaparib, AZD5363 and Durvalumab has beneficial effects in advanced or metastatic

  • 0 views
  • 22 Jan, 2021
  • 1 location
  • 6 views
  • 23 Mar, 2022
  • 3 locations
Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

This is a Phase 1, open-label, multicenter, dose-escalation/dose-expansion study of YBL-006, in participants with Advanced Solid Tumors. This multicenter study will be conducted in approximately

  • 0 views
  • 07 Oct, 2021
  • 8 locations